2 Under-the-Radar Biotech Stocks Worth Buying for the Long Term [Globe and Mail, The (Toronto, Canada)]
Vertex Pharmaceuticals Incorporated (VRTX)
Last vertex pharmaceuticals incorporated earnings: 4/29 04:01 pm
Check Earnings Report
US:NASDAQ Investor Relations:
investors.vrtx.com
Company Research
Source: Globe and Mail, The
Both companies have been expanding through acquisitions. Vertex Pharmaceuticals (NASDAQ: VRTX) and Mirum Pharmaceuticals (NASDAQ: MIRM) are two biotech stocks that share the same blueprint. They are focusing on rare diseases with highly unmet medical needs and are using their successful therapies to broaden their platforms. Vertex has built its financial foundation on its dominance in cystic fibrosis (CF) therapies. Mirum is seeking to widen its platform beyond rare cholestatic liver diseases. Will AI create the world's first trillionaire? Our team just released a report on the one little-known company, called an "Indispensable Monopoly" providing the critical technology Nvidia and Intel both need. Continue » So far this year, Vertex's shares are down more than 2% and Mirum's are up more than 20%. I believe each of these under-the-radar biotech companies is worth buying. Here are three reasons why I like each stock: Image source: Getty Images. Mirum is showing explosive r
Show less
Read more
Impact Snapshot
Event Time:
VRTX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
VRTX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
VRTX alerts
High impacting Vertex Pharmaceuticals Incorporated news events
Weekly update
A roundup of the hottest topics
VRTX
News
- Is Halozyme Therapeutics (HALO) One of the Most Undervalued Biotech Stocks to Buy Right Now? [Yahoo! Finance]Yahoo! Finance
- 2 Under-the-Radar Biotech Stocks Worth Buying for the Long Term [Yahoo! Finance]Yahoo! Finance
- How an unsolved medical mystery became a life-saving breakthrough [USA TODAY]USA TODAY
- Is Vertex Pharmaceuticals' Empire in Trouble? [Globe and Mail, The (Toronto, Canada)]Globe and Mail, The
- Is Vertex Pharmaceuticals' Empire in Trouble? [Yahoo! Finance]Yahoo! Finance
VRTX
Earnings
- 2/12/26 - Beat
VRTX
Sec Filings
- 4/17/26 - Form 4
- 4/17/26 - Form 4
- 4/17/26 - Form 4
- VRTX's page on the SEC website